BRIMO-VISION gtt opht 2 mg/ml 180 monodos 0.35 ml
7680673120040
CH-67312
S01EA05
11.09.0.
1 / 3
google
Details
- Product number
- 6731201
- CPT
- -
- Packaging group
- 180 x 0.35
- Unit
- ml
- Composition
- brimonidini tartras 2 mg corresp. brimonidinum 1.32 mg, excipiens ad solutionem pro 1 ml.
Articles (1)
Brimo-Vision 2 mg/ml, Augentropfen (Einzeldosen)
Augentropfen
180 x 0.35
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
1.32 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 38.10
Specialties list
Yes
Generic
Yes
SL addition date:
01/03/2021
Authorization holder
OmniVision AG
8212 Neuhausen am Rheinfall
Authorization information
- Swissmedic authorization number
- 67312
- Drug name
- Brimo-Vision, Augentropfen, Lösung im Einzeldosisbehältnis
- Galenic form
- AUTLE
- ATC Code
- S01EA05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 25/03/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 11.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BRIMO-VISION gtt opht 2 mg/ml 180 monodos 0.35 ml
- Description (DE)
- BRIMO-VISION Gtt Opht 2 mg/ml 180 Monodos 0.35 ml
- Market launch
- 25/03/2020
- Narcotic (BTM)
- No